Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +


Lonza and Forty Seven announce strategic manufacturing agreement for immuno-oncology therapeutic antibody pipeline

October 20, 2016

Lonza will manufacture material at its Slough (UK) facility for Forty Sevenís ongoing and futur ...

Ingredients | Manufacturing and Equipment

Nordic Nanovector and LegoChem Biosciences collaborate to develop novel antibody-drug conjugates (ADCs) targeting leukaemias

October 11, 2016

Leukemias are orphan diseases with a significant unmet medical need, representing a growing mar ...

Ingredients | R and D | Asia

CRT and University of Copenhagen announce agreement with ADC Therapeutics to develop antibody treatments for cancer

April 22, 2016

The antibodies target an overexpressed protein on the surface of some cancer cells, which is no ...

Ingredients | R and D

ProBioGen and Eucodis agree to commercialise a novel antibody drug conjugation technology

April 22, 2016

The one-step C-LiNK coupling technology will open up the development space for ADCs and represe ...

Ingredients | Drug Delivery | R and D | Finance

CMC Biologics and IDT Biologika collaborate to manufacture antibody drug conjugates

February 19, 2016

Alliance will provide an efficient end-to-end solution for the development and manufacture of A ...

Ingredients | Finance | Manufacturing and Equipment

Pharmaceutical deals crucial to offsetting US$2.5bn cost of novel drug development

December 18, 2015

The shift from small molecules to large molecules, such as antibodies and proteins, has created ...

Ingredients | Regulatory | R and D | Finance

BioAtla and Pfizer to develop a new class of antibody therapeutics

December 11, 2015

Agreement combines BioAtla's conditionally active biologic (CAB) antibodies with Pfizer's propr ...

Ingredients | Drug Delivery | R and D | Finance